Lemieux 2011 Int J Biochem Cell Biol
|Lemieux H, Semsroth S, Antretter H, Höfer D, Gnaiger E (2011) Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol 43:1729–38.|
Abstract: O2k-in brief
Heart failure is a consequence of progressive deterioration of cardiac performance. Little is known about the role of impaired oxidative phosphorylation in the progression of the disease, since previous studies of mitochondrial injuries are restricted to end-stage chronic heart failure. The present study aimed at evaluating the involvement of mitochondrial dysfunction in the development of human heart failure. We measured the control of oxidative phosphorylation with high-resolution respirometry in permeabilized myocardial fibres from donor hearts (controls), and patients with no or mild heart failure but presenting with heart disease, or chronic heart failure due to dilated or ischemic cardiomyopathy. The capacity of the phosphorylation system exerted a strong limitation on oxidative phosphorylation in the human heart, estimated at 121 pmol O2•s˗1•mg˗1 in the healthy left ventricle. In heart disease, a specific defect of the phosphorylation system, Complex I-linked respiration, and mass-specific fatty acid oxidation were identified. These early defects were also significant in chronic heart failure, where the capacities of the oxidative phosphorylation and Electron transfer-pathway per cardiac tissue mass were decreased with all tested substrate combinations, suggesting a decline of mitochondrial density. Oxidative phosphorylation and Electron transfer-pathway capacities were higher in ventricles compared to atria, but the impaired mitochondrial quality was identical in the four cardiac chambers of chronic heart failure patients. Coupling was preserved in heart disease and chronic heart failure, in contrast to the mitochondrial dysfunction observed after prolonged cold storage of cardiac tissue. Mitochondrial defects in the phosphorylation system, Complex I respiration and mass-specific fatty acid oxidation occurred early in the development of heart failure. Targeting these mitochondrial injuries with metabolic therapy may offer a promising approach to delay the progression of heart disease.
• Keywords: Oxidative phosphorylation, Mitochondrial respiratory control, Human heart disease and heart failure, Permeabilized cardiac fibres, Cold storage, High-resolution respirometry
Labels: MiParea: Respiration, mt-Biogenesis;mt-density, mt-Medicine, Patients Pathology: Cardiovascular Stress:Ischemia-reperfusion Organism: Human Tissue;cell: Heart Preparation: Permeabilized tissue Enzyme: Marker enzyme Regulation: Coupling efficiency;uncoupling, Cyt c, Fatty acid Coupling state: LEAK, OXPHOS, ET Pathway: F, N, S, CIV, NS, ROX HRR: Oxygraph-2k, O2k-Protocol
1PM;2D;3G;4U;5S;6Rot-, 1PalM;2D;3Oct;4P;5G;6U;7S;8Rot-, SUIT-019, SUIT-019 O2 pfi D045
- Increased OXPHOS capacity after cold preservation of the human heart – a paradox resolved by a dyscoupling mechanism.
- Human heart failure: mtDNA versus CS and PGC-1a pathway - PGC-1alpha
- Tissue storage